AU8113294A - Treatment of a patient prior to transplantation - Google Patents

Treatment of a patient prior to transplantation

Info

Publication number
AU8113294A
AU8113294A AU81132/94A AU8113294A AU8113294A AU 8113294 A AU8113294 A AU 8113294A AU 81132/94 A AU81132/94 A AU 81132/94A AU 8113294 A AU8113294 A AU 8113294A AU 8113294 A AU8113294 A AU 8113294A
Authority
AU
Australia
Prior art keywords
transplantation
treatment
patient prior
patient
prior
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU81132/94A
Inventor
Johan Herman Frederik Falkenburg
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Universiteit Leiden
Original Assignee
Universiteit Leiden
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Universiteit Leiden filed Critical Universiteit Leiden
Publication of AU8113294A publication Critical patent/AU8113294A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/289—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against CD45
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
AU81132/94A 1993-11-10 1994-11-10 Treatment of a patient prior to transplantation Abandoned AU8113294A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9323199 1993-11-10
GB939323199A GB9323199D0 (en) 1993-11-10 1993-11-10 Leukaemia treatment
PCT/GB1994/002470 WO1995013093A1 (en) 1993-11-10 1994-11-10 Treatment of a patient prior to transplantation

Publications (1)

Publication Number Publication Date
AU8113294A true AU8113294A (en) 1995-05-29

Family

ID=10744958

Family Applications (1)

Application Number Title Priority Date Filing Date
AU81132/94A Abandoned AU8113294A (en) 1993-11-10 1994-11-10 Treatment of a patient prior to transplantation

Country Status (3)

Country Link
AU (1) AU8113294A (en)
GB (1) GB9323199D0 (en)
WO (1) WO1995013093A1 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3960764A1 (en) 2006-11-03 2022-03-02 The Board of Trustees of the Leland Stanford Junior University Selective immunodepletion of endogenous stem cell niche for engraftment
EP3530274A1 (en) * 2010-08-18 2019-08-28 Theresa Deisher Dexamethasone to reduce stem cell accumulation in the spleen
US10426740B1 (en) 2010-08-18 2019-10-01 Avm Biotechnology, Llc Compositions and methods to inhibit stem cell and progenitor cell binding to lymphoid tissue and for regenerating germinal centers in lymphatic tissues
KR20180026370A (en) 2015-04-06 2018-03-12 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 Compositions and methods for non-myelosuppressive conditioning
IL263744B2 (en) 2016-06-17 2023-11-01 Magenta Therapeutics Inc Compositions and methods for the depletion of cd117 plus cells
BR112018076263A2 (en) 2016-06-17 2019-03-26 Magenta Therapeutics, Inc. compositions and methods for cell depletion
BR112019014991A2 (en) 2017-01-20 2020-04-07 Magenta Therapeutics Inc compositions and methods for the suppression of cd137 + cells
EP3490605B1 (en) 2017-04-01 2023-06-07 AVM Biotechnology, LLC Replacement of cytotoxic preconditioning before cellular immunotherapy
EP3488851A1 (en) 2018-10-03 2019-05-29 AVM Biotechnology, LLC Immunoablative therapies
GB202015226D0 (en) 2020-09-25 2020-11-11 Adc Therapeutics S A Pyrrol obenzodiazepine-antibody conugates and uses thereof
GB202015235D0 (en) 2020-09-25 2020-11-11 Ucl Business Plc Anti-CD45 antibodies and related therapeutics

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4710457A (en) * 1983-06-29 1987-12-01 Sloan-Kettering Institute For Cancer Research Monoclonal antibody for human hematopoietic glycoproteins and method
US5273738A (en) * 1990-03-03 1993-12-28 Fred Hutchinson Cancer Research Center Radiation delivery to lymphoid and marrow tissues
CA2121235A1 (en) * 1991-10-18 1993-04-29 Hirsch D. Taube In vitro antibody perfusion of kidney grafts

Also Published As

Publication number Publication date
WO1995013093A1 (en) 1995-05-18
GB9323199D0 (en) 1994-01-05

Similar Documents

Publication Publication Date Title
AU6797094A (en) Cosmetic treatment of substrates
AU665899B2 (en) Artificial heart
AU7867994A (en) Hemofiltration of mediator-related diseases
AU2300092A (en) Prostaglandin e2 treatment of impotence
AU7205894A (en) Purified natural and synthetic compounds for the treatment of osteoarthritis
AU1173195A (en) Treatment of immunoregulatory disorders
AU3072989A (en) Skin treatment composition
AU1115095A (en) Treatment of cellulose
AU8113294A (en) Treatment of a patient prior to transplantation
AU3730093A (en) Methods of treating diabetes
GB9313188D0 (en) Medical use of enzymes
AU2685892A (en) Method of treating blood
AU5340594A (en) Skin treatment
AU3836489A (en) Treatment of immunodeficiency
AU3553489A (en) Novel compounds and treatment
IL107768A0 (en) Treatment of agricultural produce
AU7565894A (en) Acupuncture treatment of common baldness
AU1304895A (en) Peptides to overcome inhibition of nerve growth
AU8185491A (en) Treatment of disease
AU7209394A (en) Gallium complexes for the treatment of free radical-induced diseases
AU5419894A (en) Dental treatment aid
AU6863191A (en) Treatment of protozoal diseases
AU1604692A (en) Treatment of longitudinally extending members
AU8819691A (en) Treatment of gas
AU3518693A (en) Therapeutic earring